Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study-Reference-Cited by-同舟云学术

Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study

Published:2020-09-15 Issue:11 Volume:26 Page:1708-1713
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Liu Sean T. H.^ORCID,Lin Hung-Mo,Baine Ian,Wajnberg Ania,Gumprecht Jeffrey P.,Rahman Farah,Rodriguez Denise,Tandon Pranai,Bassily-Marcus Adel,Bander Jeffrey,Sanky Charles,Dupper Amy,Zheng Allen^ORCID,Nguyen Freddy T.^ORCID,Amanat Fatima,Stadlbauer Daniel^ORCID,Altman Deena R.^ORCID,Chen Benjamin K.,Krammer Florian^ORCID,Mendu Damodara Rao,Firpo-Betancourt Adolfo,Levin Matthew A.^ORCID,Bagiella Emilia,Casadevall Arturo,Cordon-Cardo Carlos,Jhang Jeffrey S.,Arinsburg Suzanne A.,Reich David L.,Aberg Judith A.^ORCID,Bouvier Nicole M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-020-1088-9.pdf

Reference31 articles.

1. Casadevall, A. & Pirofski, L. A. The convalescent sera option for containing COVID-19. J. Clin. Invest. 130, 1545–1548 (2020).

2. Rojas, M. et al. Convalescent plasma in COVID-19: possible mechanisms of action. Autoimmun. Rev. 19, 102554 (2020).

3. Sharun, K. et al. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects. Expert Opin. Biol. Ther. 20, 1033–1046 (2020).

4. Richardson, S. et al. Presenting characteristics, comorbidities and outcomes among 5,700 patients hospitalized with COVID-19 in the New York City area. JAMA 323, 2052–2059 (2020).

5. Duan, K. et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc. Natl Acad. Sci. USA 117, 9490–9496 (2020).

Cited by 394 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing;International Journal of Biological Macromolecules;2024-10

2. Characterization of therapeutic antibody efficacy against multiple SARS-CoV-2 variants in the hamster model;Antiviral Research;2024-10

3. Correlates of improved outcomes in patients with COVID-19 treated in US emergency departments;The American Journal of Emergency Medicine;2024-09

4. Impact of Medical–Pharmaceutical Separation Reform on Hospitalization Expenditure in Tertiary Public Hospitals: Difference-in-Difference Analysis Based on Panel Data from Beijing;Risk Management and Healthcare Policy;2024-05

5. A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system;Microbiology Spectrum;2024-04-02